Pathologic alterations in the diabetic neuropathies of humans: A review

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 12, 1996, Pages 1181-1193

  Dyck, Peter James ^a   Giannini, Caterina ^a,b  

^a MAYO CLINIC   (United States)

^b OSPEDALE CA FONCELLO   (Italy)

Author keywords

Carpal tunnel syndrome; Cubital tunnel syndrome; Diabetic neuropathy; Diabetic oculomotor neuropathy; Diabetic polyneuropathy; Pathology; Proximal diabetic neuropathy

Indexed keywords

CARPAL TUNNEL SYNDROME; CUBITAL TUNNEL SYNDROME; DEMYELINATION; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; MICROANGIOPATHY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; PRIORITY JOURNAL; RADICULOPATHY; REPETITIVE STRAIN INJURY; REVIEW; RISK FACTOR; VASCULITIS;

EID: 0029954190     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199612000-00001     Document Type: Review

References (113)

1. Crofford O. Report of the National Commission on Diabetes. A review of the scope of diabetes as it affects the United States with epidemiologic, economic, and sociologic data. In: DHEW (NIH) publication. Washington, DC: U.S. Government Press, 1975:75-108
2. Palumbo PJ, Elveback LR, Chu C-R Connolly DC, Kurland LT. Diabetes mellitus: Incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes 1976;25: 566-77
3. Akerblom HK, Reunanet A. The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in Northern Europe. Diabetes Care 1985;8:10-16
4. Dahlquist O, Blom L, Holmgren G, et al. The epidemiology of diabetes in Swedish children 0-14 years - a six-year prospective study. Diabetologia 1985;28:802-8
5. Lorenzi M, Cagliero E, Schmidt NJ. Racial differences in incidence of juvenile-onset type I diabetes: Epidemiologic studies in southern California. Diabetologia 1985;28:734-38
6. Newrick PG, Boulton AJM, Ward JD. The distribution of diabetic neuropathy in a British clinic population. Diabetes Res Clin Pract 1986;2:263-68
7. Mason DR, Scott RS, Darlow BA. Epidemiology of insulin-dependent diabetes mellitus in Canterbury, New Zealand. Diabetes Res Clin Pract 1987;3:21-29
8. Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988;37:1113-17
9. Wagenknecht LE, Roseman JM, Alexander J. Epidemiology of IDDM in black and white children in Jefferson County, Alabama, 1969-1985. Diabetes 1989;38:629-33
10. Diabetes Epidemiology Research International Group. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 1990;39:858-64
11. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester diabetic neuropathy study. Neurology 1993;43:817-24
12. Halter JB, Porte D, Jr. The clinical syndrome of diabetes mellitus. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, Jr., eds. Diabetic neuropathy. Philadelphia: W. B. Saunders Company, 1987:3-26
13. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B.Saunders Company, 1993:1219-50
14. Garland HT, Taverner D. Diabetic myelopathy. Br Med J 1953;1: 1405-8
15. Garland H. Diabetic amyotrophy. Br Med J 1955;2:1287-96
16. Goodman JI. Femoral neuropathy in relation to diabetes mellitus: Report of 17 cases. Diabetes 1954;3:266-73
17. Skanse B, Gydell K. A rare type of femoral-sciatic neuropathy in diabetes mellitus. Acta Med Scand 1956;155:463-68
18. Calverley JR, Mulder DW. Femoral neuropathy. Neurology 1960;10:963-71
19. Williams IR, Mayer RF. Subacute proximal diabetic neuropathy. Neurology 1976;26:108-16
20. Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy) revisited 100 years later. Arch Neurol 1991;48:1130-35
21. Asbury AK. Proximal diabetic neuropathy. Ann Neurol 1977;2: 179-90
22. Chokroverty S, Reyes MG, Rubino FA. Bruns-Garland syndrome of diabetic amyotrophy. Trans Am Neurol Ass 1977;102:1-4
23. Jordan WR. Neuritis manifestations in diabetes mellitus. Arch Intern Med 1936;57:307-66
24. Rundles RW. Diabetic neuropathy: General review with report of 125 cases. Medicine (Baltimore) 1945;24:111-21
25. Woltman HW, Wilder RM. Diabetes mellitus: Pathological changes in the spinal cord and peripheral nerves. Arch Intern Med 1929;44:576-603
26. Martin MM. Diabetic neuropathy. A clinical study of 150 cases. Brain 1953;76:594-603
27. Dolman CL. The pathology and pathogenesis of diabetic neuropathy. Bull N Y Acad Med 1967;43:773-83
28. Auche MB. Des alterations des nerfs peripheriques. Arch Med Exp Anat Pathol 1890;2:635-76
29. Fraser TR, Bruce A. On a case of diabetic neuritis with a description of the postmortem examination of the nerves and muscles. Edinburgh Med J 1896;42:300-307
30. Pryce TD. On diabetic neuritis with a clinical and pathological description of three cases of diabetic psuedo-tabes. Brain 1893;16: 416
31. Leichtentritt H. Erkrankung Peripherer nerven und des rückenmarks bei diabetes mellitus. Berlin: G. Schade, 1893:1-32
32. Williamson RT. Changes in the spinal cord in diabetes mellitus. Br Med J 1904:1:122
33. Renaut MJ. Recherches sur quelques points particuliers de l'histologie des nerfs. I. La gaine lamelleuse et le systeme hyalin intravaginal. Arch N Psych 1881;8:161-90
34. Reske-Nielsen E, Lundbaek K. Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia 1968;4:34-43
35. Reske-Nielsen E, Gregersen G, Harmsen A, Lundbaek K. Morphological abnormalities of the terminal neuromuscular apparatus in recent juvenile diabetes. Diabetologia 1970;6:104-9
36. Thomas PK, Lascelles RG. The pathology of diabetic neuropathy. Q J Med 1966;35:480-509
37. Bischoff A. Die Ultrastruktur peripherer nerven bei der diabetischen neuropathic. Dtsch Gesellschaft Innere Med 1967;18:1138-41
38. Ballin RHM, Thomas PK. Hypertrophic changes in diabetic neuropathy. Acta Neuropathol (Berl) 1968;11:93
39. Chopra JS, Connon JJ, Banerji NK. Diabetic neuropathy - clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects. Diabetologia 1969;5:413-15
40. Arne L, Vital C, Vallat JM, Yung A, LeBlanc M, Martin E Diabetic peripheral neuropathy. Anatomoclinical study with ultrastructure of a nerve biopsy. Rev Neural (Paris) 1972;126:115-26
41. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072-82
42. Said G, Slama G, Salva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 1983;106:791-807
43. Dyck PJ, Hansen S, Karnes J, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 1985;82:2513-17
44. Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ, Muddle JR. Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes. Diabetologia 1988;31:162-67
45. Britland ST, Young RJ, Sharma AK, Clarke BF. Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 1990;39:909-13
46. Yagihashi S, Matsunaga M. Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 1979;129:357-66
47. Kanda T. Morphometric analysis of sural nerve in elderly diabtes mellitus. Bull Tokyo Med Den U 1984;31:209-24
48. Sugimura K, Dyck PJ. Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy. J Neurol Sci 1982;53:501-9
49. Dyck PJ, Karnes JL, O'Brien PC, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19:440-49
50. Chopra JS, Hurwitz LJ, Montgomery DAD. The pathogenesis of sural nerve changes in diabetes mellitus. Brain 1969;92:391-418
51. Lambert EH, Dyck PJ. Compound action potentials of sural nerve in vitro in peripheral neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W. B. Saunders, 1993:672-84
52. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986;19:425-39
53. Huang CY, Walsh JC. Pathologic changes in the greater splanchnic nerve of subjects with diabetic peripheral neuropathy. Proc Austr Assoc Neurol 1973;10:13-18
54. Appenzeller O, Ogin G. Myelinated fibers in human paravertebral sympathetic chain: White rami communicantes in alcoholic and diabetic patients. J Neurol Neurosurg Psychiatry 1974;37:1155
55. Behse F, Buchthal F; Carlsen F, Knappeis GG. Endoneurial space and its constituents in the sural nerve of patients with neuropathy. Brain 1974;97:773-84
56. Lascelles RG, Thomas PK. Changes due to age in internodal length in the sural nerve in man. J Neurol Neurosurg Psychiatry 1966;29:40-44
57. Vital C, Vallat JM, LeBlanc M, Martin F, Coquet M. Peripheral neuropathies caused by diabetes mellitus. Ultrastructural study of 12 biopsied cases. J Neurol Sci 1973;18:381-98
58. Vital C, LeBlanc M, Vallat JM, Cocquet M, Vallat M, Roques JC. Ultrastructural study of peripheral nerve in 16 diabetics without neuropathy. Comparisons with 16 diabetic neuropathies and 16 non-diabetic neuropathies. Acta Neuropathol (Berl) 1974;30:63-72
59. Medori R, Autilio-Gambetti B, Monaco B, Gambetti P. Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci USA 1985;82:7716-20
60. Jakobsen J. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves. Diabetologia 1976;12:539-46
61. Thomas PK, Fraher JP, O'Leary D, Moran MA, Cole M, King RHM. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocininduced diabetes. Acta Neuropathol (Berl) 1990;79:375-86
62. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971;46:400-31
63. Dyck PJ. Morphometric evaluation of peripheral nerve. Transactions 8th International Congress of Electroencephalography and Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1974;36:571-72
64. Dyck PJ, Giannini C, Lais A. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, Low PA, Griffin JW, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993:514-95
65. Sugimura K, Dyck PJ. Sural nerve myelin thickness and axis cylinder caliber in human diabetes. Neurology 1981;31:1087-91
66. Gerrard JM, Stuart MJ, Rao GHR, et al. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 1980;95:950-58
67. Bradley JL, Thomas PK, King RH, et al. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: Correlation with type of diabetes. Acta Neuropathol (Berl) 1995;90:403-10
68. Sima AAF, Lattimer SA, Hagihashi S, Greene DA. Axoglial dysjunction. A novel structural lesion that accounts for poorlyreversible nerve conduction slowing in the spontaneously-diabetic Bio-breeding rat. J Clin Invest 1986;77:474-85
69. Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axoglial dysjunction in human diabetic neuropathy. J Clin Invest 1988;81: 349-64
70. Giannini C, Dyck PJ. Axoglial dysjunction: A critical appraisal of definition, techniques, and previous results. MRT 1996;34:436-44
71. Phillips DD, Hibbs RG, Ellison JP, Shapiro H. An electron microscopic study of central and peripheral nodes of Ranvier. J Anat 1972;111:229-38
72. Dyck PJ, Zimmerman BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988;319:542-48
73. Fagerberg S-E. Diabetic neuropathy. A clinical and histological study on the significance of vascular affections. Acta Med Scand 1959;164(suppl.345):1-99
74. Bergstrand A, Bucht H. Electron microscopic investigations on the glomerular lesions in diabetic mellitus. Lab Invest 1957;6: 293-300
75. Farquhar MG, Hopper J, Moon HD. Diabetic glomerulosclerosis: Electron and light microscopic studies. Am J Pathol 1959;35: 721-53
76. Toussaint D, Dustin P. Electron microscopy of normal and diabetic retinal capillaries. Arch Ophthalmol 1963;70:96-108
77. Dachs S, Churg J, Mautner W, Grisham E. Diabetic nephropathy. Am J Pathol 1964;44:155-61
78. Friederici HHR, Tucker WR, Schwartz TB. Observations on small blood vessels of skin in the normal and in diabetic patients. Diabetes 1966;15:233-50
79. Yodaiken RE, Seftel HC, Rubenstein AN. Ultrastructure of dermal capillaries of Africans in South Africa. Diabetes 1967;16:191-97
80. Timperly WR, Ward JD, Preston FE, Duckworth T, O'Mally BC. Clinical and histological studies in diabetic neuropathy: A reassessment of vascular factors in relation to vascular coagulation. Diabetologia 1976;12:237-43
81. Williams E, Timperly WR, Ward JD, Duckworth T. Electron microscopic studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980;33:462-70
82. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32: 92-102
83. Yasuda H, Dyck PJ. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987;37:20-28
84. Giannini C, Dyck PJ. Ultrastructural morphometric features of human sural nerve endoneurial microvessels. J Neuropathol Exp Neurol 1993;52:361-69
85. Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 1994;36:408-15
86. Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropa thy and are associated with its severity. Ann Neurol 1995;37:498-504
87. Poduslo JF, Low PA, Windebank AJ, Dyck PJ, Berg CT, Schmelzer JD. Altered blood-nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration. J Neurosci 1982;2:1507-14
88. Dyck PJ, Lambert EH, Windebank AJ, et al. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 1981;71:507-14
89. DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-45
90. DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995;122:561-68
91. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990;322:1031-37
92. Eliasson S. Nerve conduction changes in experimental diabetes. J Clin Invest 1964;43:2353-57
93. Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care 1993;16:8-15
94. Kinoshita JH. Cataracts in galactosemia. Invest Ophthalmol 1965;4:786-99
95. Gregersen G, Bertelsen B, Harbo H. Oral supplementation of myoinositol: Effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurol Scand 1983;67:164-72
96. Gregersen G, Borsting H, Theil P, Servo C. Myoinositol and function of peripheral nerves in human diabetics: A controlled clinical trial. Acta Neurol Scand 1978;58:241-48
97. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21
98. Dyck PJ. Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg Lecture. Neurology 1989;39:111-18
99. Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 1984;81:6894-98
100. Low PA, Schmelzer JD, Ward KK, Yao JK. Experimental chronic hypoxic neuropathy: Relevance to diabetic neuropathy. Am J Physiol 1986;251:E94-E99
101. Johnson PC, Doll SC, Cromey DW. Pathogenesis of diabetic neuropathy. Ann Neurol 1986;19:450-57
102. Benstead TJ, Dyck PJ, Sangalang V. Inner perineurial cell vulnerability in ischemia. Brain Res 1989;489:177-81
103. Raff MC, Sangalang V, Asbury AK. Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol 1968;18: 487-93
104. Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in diabetic neuropathy - a clinical and pathological study. Brain 1975;98:357-64
105. Low PA. Clinical autonomic disorders: Evaluation and management. Boston: Little, Brown and Company, 1993
106. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes. Ann Intern Med 1980;92:301
107. Stevens JC, Sun S, Beard CM, O'Fallon WM, Kurland LT. Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology 1988;38:134-38
108. Ochoa J, Danta G, Fowler TJ, Gilliatt RW. Nature of the nerve lesion caused by a pneumatic tourniquet. Nature 1971;233:265-66
109. Dyck PJ, Lais AC, Giannini C, Engelstad JK. Structural alterations of nerve during cuff compression. Proc Natl Acad Sci USA 1990;87:9828-32
110. Dreyfus PM, Hakim S, Adams RD. Diabetic ophthalmoplegia. Arch Neurol Psychiat 1957;77:337-49
111. Asbury AK, Aldredge H, Herschberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: A clinicopathological study. Brain 1970;93:555-66
112. Sidenius P, Jakobsen J. Anterograde fast component of axonal transport during insulin-induced hypoglycemia in nondiabetic and diabetic rats. Diabetes 1987;36:853-58
113. Yasaki S, Dyck PJ. Spatial distribution of fiber degeneration in acute hypoglycemic neuropathy in rat. J Neuropathol Exp Neurol 1991;50:681-92